Sequencing and bacterial analysis supplies

Ended Purchase Order Awarded

Contract number
HT941026PE068
Awardee
Awarding agency
Obligated
$273,352

Award facts

Opportunity
Contract value 100% obligated
$273,351.68 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92122, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency awarded a purchase order to Illumina, Inc. for sequencing and bacterial analysis supplies with a ceiling value of $273,351.68, effective May 30, 2026. Work is performed in San Diego, California. The order supports Tripler Army Medical Center's Department of Clinical Investigation in Hawaii with urinary pathogen identification and antimicrobial resistance enrichment kits for Government-owned MiSeq Systems, with an ultimate completion date of September 30, 2026. The procurement was issued on a sole-source basis; Illumina was determined to be the exclusive vendor capable of providing supplies compatible with the facility's sequencing instruments.

Quick answers

Who was awarded contract HT941026PE068?

HT941026PE068 was awarded to Illumina, Inc. by Defense Health Agency (Department of Defense) on May 30, 2026.

How much is contract HT941026PE068 worth?

The government has obligated $273,352 on HT941026PE068.

Was contract HT941026PE068 competed?

The extent of competition for HT941026PE068 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award